Mashup Score:13
New York TimesThe Vanishing Variants: Lessons from Gamma, Iota and Mu - 3 weeks
Mashup Score:13
Twitter Feed: David Johnson
Mashup Score:5
JAMA NetworkAssociation of Race With Receipt of Proton Beam Therapy for Patients With Cancer - 3 weeks
Mashup Score:5
This cross-sectional study of Black and White patients with cancer assesses racial disparities in the receipt of proton beam...
-
Asso'n of race w/ receipt of PBT for cancer pts. 🤔 @UTSWHemeOnc @utswcancer @guptaarjun90 @TimothyJBrownMD @JVentoMD @JasmineSukumar @alaccetti @timilpatel @trile1988 https://t.co/iCyYFhyysE via @JAMANetworkOpen part of @JAMANetwork - view on twitter
Mashup Score:5
www.obroncology.comFDA Advisory Panel Calls for Randomized Data for PI3K Inhibitor Approvals for Blood Cancers - 1 month
Mashup Score:5
An FDA Oncologic Drugs Advisory Committee (ODAC), meeting on April 21, voted almost unanimously to recommend that drug companies conduct randomized clinical trials before...
-
ICYMI: ODAC wants RCTs for PI3K inhibitors. The challenge of surrogate endpoints. @utswcancer @UTSWHemeOnc @TimothyJBrownMD @guptaarjun90 @JasmineSukumar @JVentoMD @rmelias2 @trile1988 @alaccetti @timilpatel https://t.co/b9fyWoEsK9 #OBRoncology via @OBRTweets - view on twitter
More coverage:
#obroncology
Mashup Score:4
auwpod.libsyn.comASCO Education Podcast: Oncology, Etc. – Mr. Paul Goldberg: Interviewing the Interviewer (Part 2) - 1 month
Mashup Score:4
Drs. David Johnson (University of Texas) and Patrick Loehrer (Indiana University) host the second half second half of their Oncology, Etc. interview with Mr....
-
Here's part 2 of our interview with Paul Goldberg, take a listen! @utswcancer @UTSWIMchief @UTSWInternalMed @ASCO @ASCOPost @guptaarjun90 @TimothyJBrownMD @JVentoMD @alaccetti @JasmineSukumar @trile1988 @timilpatel @rmelias2 https://t.co/5Bxo6YCwIp - view on twitter
Mashup Score:3
Washington PostOpinion | No Republican who participates in the war on truth deserves your vote - 4 weeks
Mashup Score:3
A contest between liberal and conservative philosophies is healthy. An asymmetrical clash between reality and paranoid fiction is dangerously...
-
I ask again, when did lying become an apparent virtue & political asset? “Any fellow who will cheat for you will cheat against you.” - Sam Rayburn https://t.co/Md2mLAFaPk - view on twitter
Mashup Score:3
JAMA NetworkMedical Documentation Burden Among US Office-Based Physicians - 3 weeks
Mashup Score:3
This cross-sectional study uses data from the 2019 National Electronic Health Records Survey to assess the burden and time spent on medical documentation outside...
-
ICYMI: Burden of medical documentation on US office-based MDs. What, me worry? @UTSWIMchief @UTSWInternalMed @DinoKazi https://t.co/5QbApwBFFC via @JAMAInternalMed part of @JAMANetwork - view on twitter
Mashup Score:2
ForbesAmerica’s Best Employers For Diversity 2022 - 4 weeks
Mashup Score:2
Forbes partnered with market research company Statista to survey 60,000 Americans and pinpoint the companies they identified as most dedicated to diversity, equity and...
-
ICYMI: Among healthcare systems @UTSWNews is tops (#19 overall). @UTSWIMchief @UTSWInternalMed @DinoKazi @thomasjwang1 https://t.co/ARUxGsfBq9 - view on twitter
Mashup Score:2
auwpod.libsyn.comIn the second of this two-part conversation Drs. Patrick Loehrer and David Johnson sit down with Dr. Deborah Schrag, the current Chair of the...
-
ICYMI: Dr. Schrag discusses the Joy in Medicine. A must listen. @ASCO @ConquerCancerFd @utswcancer @UTSWHemeOnc @UTSW_LungLadies @DinoKazi @UTSW_IMdei @swag_utswim @UTSWFacultyDev https://t.co/VaXFNrsZPQ - view on twitter
Mashup Score:2
JAMA NetworkProton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004-2018 - 3 weeks
Mashup Score:2
This cross-sectional study assesses the changes in the use of proton beam radiotherapy in the treatment of cancers in the US over...
-
ICYMI: PBT use among pts w/ newly dx'd cancer in US. @UTSWIMchief @UTSWInternalMed @utswcancer @UTSWHemeOnc @JasmineSukumar @alaccetti @JVentoMD @timilpatel @trile1988 @TimothyJBrownMD @guptaarjun90 https://t.co/cq5nuiohOz via @JAMANetworkOpen part of @JAMANetwork - view on twitter
Mashup Score:1
The Lancet Infectious DiseasesFourth-dose COVID-19 mRNA booster vaccines are well tolerated and boost cellular and humoral immunity. Peak responses after the fourth dose were similar to, and...
-
ICYMI: Glad I got boosted. @UTSWIMchief @UTSWInternalMed @UTSWInfDis @EmilyCHoff1 @TheFrenchFellow @chc_yek @DinoKazi https://t.co/NczqO0ASwR - view on twitter
Studying the coronavirus variants that have faded away could help us prepare for what comes next, scientists...
ICYMI: The Vanishing Variants. @UTSWIMchief @UTSWInfDis @UTSWInternalMed @TheFrenchFellow @chc_yek @EmilyCHoff1 @DrJulieTMD @BradCutrellMD @RicardoLaHozMD @PerlTrish @DinoKazi https://t.co/cjTE3MEdbn - view on twitter